UNCTAD

UNDP, Unitaid, and WHO caught in Big Pharma’s crosshairs

Posted on by Thiru

Warning: call_user_func_array() expects parameter 1 to be a valid callback, function 'wp_embed_excerpt_more' not found or invalid function name in /home/keionli38/public_html/wp-includes/class-wp-hook.php on line 341

PhRMA’s Special 301 submissions are part of a yearly ritual to shape the “Special 301” Report, an annual review of the global state of intellectual property rights (IPR) protection and enforcement, conducted by the Office of the United States Trade…

9 November 2016 – WTO TRIPS Council – UNCTAD’s statement on the Report of the UN High-Level Panel on Access to Medicines

Posted on by Thiru

On Wednesday, 9 November 2016, the United Nations Conference on Trade and Development (UNCTAD) delivered the following statement at the World Trade Organization’s (WTO) TRIPS Council’s discussions of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines. UNCTAD informed WTO members that the agency had recently recommended to Secretary-General Ban Ki-moon to consider endorsement of the Report of the High Level Panel.

The Report of the United Nations High Level Panel on Access to Medicine
Continue Reading →